OKYO Pharma Statistics

Total Valuation

OKYO Pharma has a market cap or net worth of $81.34 million. The enterprise value is $77.31 million.

Market Cap	81.34M
Enterprise Value	77.31M

Important Dates

The next estimated earnings date is Friday, July 17, 2026, before market open.

Earnings Date	Jul 17, 2026
Ex-Dividend Date	n/a

Share Statistics

OKYO Pharma has 52.48 million shares outstanding. The number of shares has increased by 24.46% in one year.

Current Share Class	52.48M
Shares Outstanding	52.48M
Shares Change (YoY)	+24.46%
Shares Change (QoQ)	-17.58%
Owned by Insiders (%)	31.88%
Owned by Institutions (%)	12.96%
Float	28.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.58

Current Ratio	0.58
Quick Ratio	0.53
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-31.84

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-104.63%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	183.14%
Weighted Average Cost of Capital (WACC)	4.56%
Revenue Per Employee	n/a
Profits Per Employee	-$1.15M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-1.85M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.25% in the last 52 weeks. The beta is 0.02, so OKYO Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.02
52-Week Price Change	-37.25%
50-Day Moving Average	1.61
200-Day Moving Average	1.93
Relative Strength Index (RSI)	45.33
Average Volume (20 Days)	61,217

Short Selling Information

The latest short interest is 124,433, so 0.24% of the outstanding shares have been sold short.

Short Interest	124,433
Short Previous Month	162,711
Short % of Shares Out	0.24%
Short % of Float	0.44%
Short Ratio (days to cover)	2.50

Income Statement

Revenue	n/a
Gross Profit	-6.26M
Operating Income	-6.25M
Pretax Income	-6.46M
Net Income	-4.61M
EBITDA	-6.25M
EBIT	-6.25M
Earnings Per Share (EPS)	-$0.11

Full Income Statement

Balance Sheet

The company has $4.22 million in cash and $185,795 in debt, giving a net cash position of $4.03 million or $0.08 per share.

Cash & Cash Equivalents	4.22M
Total Debt	185,795
Net Cash	4.03M
Net Cash Per Share	$0.08
Equity (Book Value)	-3.42M
Book Value Per Share	-0.09
Working Capital	-3.42M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$3.10 million and capital expenditures -$1,208, giving a free cash flow of -$3.10 million.

Operating Cash Flow	-3.10M
Capital Expenditures	-1,208
Depreciation & Amortization	2,256
Net Borrowing	948,192
Free Cash Flow	-3.10M
FCF Per Share	-$0.06

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OKYO Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.46%
Shareholder Yield	-24.46%
Earnings Yield	-5.67%
FCF Yield	-3.81%

Analyst Forecast

The average price target for OKYO Pharma is $9.00, which is 480.65% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.00
Price Target Difference	480.65%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on May 22, 2023. It was a reverse split with a ratio of 1:65.

Last Split Date	May 22, 2023
Split Type	Reverse
Split Ratio	1:65

Scores

Altman Z-Score	n/a
Piotroski F-Score	2